HK1131380A1 - (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them (2r)-2-[(4-)] - Google Patents

(2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them (2r)-2-[(4-)]

Info

Publication number
HK1131380A1
HK1131380A1 HK09110159.7A HK09110159A HK1131380A1 HK 1131380 A1 HK1131380 A1 HK 1131380A1 HK 09110159 A HK09110159 A HK 09110159A HK 1131380 A1 HK1131380 A1 HK 1131380A1
Authority
HK
Hong Kong
Prior art keywords
propanamides
aminophenyl
sulfonyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK09110159.7A
Other languages
English (en)
Inventor
Marcello Allegretti
Riccardo Bertini
Cinzia Bizzarri
Maria Candida Cesta
Andrea Aramini
Alessio Moriconi
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of HK1131380A1 publication Critical patent/HK1131380A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK09110159.7A 2006-05-18 2009-10-30 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them (2r)-2-[(4-)] HK1131380A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114185 2006-05-18
PCT/EP2007/054806 WO2007135080A2 (en) 2006-05-18 2007-05-17 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
HK1131380A1 true HK1131380A1 (en) 2010-01-22

Family

ID=38353147

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110159.7A HK1131380A1 (en) 2006-05-18 2009-10-30 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them (2r)-2-[(4-)]

Country Status (23)

Country Link
US (2) US7652169B2 (xx)
EP (1) EP2024329B1 (xx)
JP (1) JP5161873B2 (xx)
KR (1) KR101422299B1 (xx)
CN (1) CN101448784B (xx)
AU (1) AU2007253424B2 (xx)
BR (1) BRPI0712064B8 (xx)
CA (1) CA2649794C (xx)
CY (1) CY1114532T1 (xx)
DK (1) DK2024329T3 (xx)
ES (1) ES2433095T3 (xx)
HK (1) HK1131380A1 (xx)
HR (1) HRP20130989T1 (xx)
IL (1) IL194939A (xx)
MX (1) MX2008013957A (xx)
NZ (1) NZ572075A (xx)
PL (1) PL2024329T3 (xx)
PT (1) PT2024329E (xx)
RS (1) RS53007B (xx)
RU (1) RU2457201C2 (xx)
SI (1) SI2024329T1 (xx)
WO (1) WO2007135080A2 (xx)
ZA (1) ZA200808907B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
KR101298651B1 (ko) * 2011-03-16 2013-08-21 연세대학교 산학협력단 효능이 강화된 혈관신생 억제용 약제학적 조성물
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
US10301378B2 (en) 2013-06-18 2019-05-28 New York University Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targets
EP3174851A1 (en) * 2014-07-31 2017-06-07 GlaxoSmithKline Intellectual Property Management Limited Use of cxcr2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
EP3884932A1 (en) 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
IL296751A (en) 2020-03-26 2022-11-01 Dompe Farm Spa cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188162B (xx) * 1999-02-05 2002-08-31 Torrent Pharmaceuticals Ltd
IT1317826B1 (it) 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
EP1776336B1 (en) * 2004-03-23 2009-09-30 DOMPE' pha.r.ma s.p.a. 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
MX2007007133A (es) * 2004-12-15 2007-08-08 Dompe Pha R Ma Spa Res & Mfg Derivados de acido 2-arilpropionico y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
WO2007135080A2 (en) 2007-11-29
NZ572075A (en) 2011-11-25
AU2007253424A1 (en) 2007-11-29
CA2649794C (en) 2016-02-16
BRPI0712064B8 (pt) 2021-05-25
CA2649794A1 (en) 2007-11-29
IL194939A (en) 2015-02-26
US7652169B2 (en) 2010-01-26
JP5161873B2 (ja) 2013-03-13
HRP20130989T1 (hr) 2013-12-06
PL2024329T3 (pl) 2014-03-31
MX2008013957A (es) 2008-11-14
RS53007B (en) 2014-04-30
SI2024329T1 (sl) 2014-01-31
CN101448784B (zh) 2012-07-04
RU2457201C2 (ru) 2012-07-27
KR20090010979A (ko) 2009-01-30
BRPI0712064A2 (pt) 2011-12-20
WO2007135080A3 (en) 2008-01-10
BRPI0712064B1 (pt) 2020-10-20
RU2008149936A (ru) 2010-06-27
EP2024329A2 (en) 2009-02-18
KR101422299B1 (ko) 2014-07-22
ZA200808907B (en) 2010-03-31
PT2024329E (pt) 2013-11-04
AU2007253424B2 (en) 2013-03-07
CY1114532T1 (el) 2016-10-05
US20100152256A1 (en) 2010-06-17
IL194939A0 (en) 2009-08-03
ES2433095T3 (es) 2013-12-09
US7868046B2 (en) 2011-01-11
US20090093530A1 (en) 2009-04-09
JP2010505742A (ja) 2010-02-25
CN101448784A (zh) 2009-06-03
DK2024329T3 (da) 2013-11-04
EP2024329B1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
HK1244267A1 (zh) 包含(r)-n-甲基納曲酮的藥物組合物
IL238308B (en) Pharmaceutical preparations containing azalastine
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
HK1131380A1 (en) (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them (2r)-2-[(4-)]
IL196168A0 (en) Biaryl compounds and pharmaceutical compositions containing the same
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
IL186336A0 (en) Pharmaceutical composition
HK1127592A1 (en) (r)-arylkylamino derivatives and pharmaceutical compositions containing them (r)-
IL185602A0 (en) Pharmaceutical compositions containing acarbose
IL186258A0 (en) Chimeric proteins, their preparation and pharmaceutical compositions containing them
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
SI1976522T1 (sl) Farmacevtski sestavek, ki vsebuje montelukast
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
IL184631A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A Wht3a PROTEIN
HUP0500813A2 (en) Pharmaceutical composition containing violaceae extract
IL190926A0 (en) A pharmaceutical composition containing a tissue protein
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
ZA200805355B (en) Pharmaceutical compositions containing protein NMA0939
ZA200808768B (en) Pharmaceutical composition containing the NMB0606 protein
TWI368614B (en) Araminone compounds, their preparations, pharmaceutical compositions containing them, and their uses
GB0500138D0 (en) Pharmaceutical composition
GB0518166D0 (en) Pharmaceutical composition
GB0511801D0 (en) Pharmaceutical composition